Clinical impact and risk factors for colonization with extended-spectrum β-lactamaseproducing bacteria in the intensive care unit

Intensive Care Medicine

Volumn 38, Issue 11, 2012, Pages 1769-1778

  Razazi, Keyvan ^a,b   Derde, Lennie P G ^c   Verachten, Marine ^d   Legrand, Patrick ^e   Lesprit, Philippe ^d   Brun Buisson, Christian ^a,b,f  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e Service de Bactériologie Virologie Hygiène   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

Antimicrobial agents; Community acquired infection; Non pulmonary nosocomial infections

Indexed keywords

CEPHALOSPORIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PROSPECTIVE STUDY; RISK ASSESSMENT; UNIVERSITY HOSPITAL;

AGED; ANTIBIOTIC PROPHYLAXIS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84868202491     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2675-0     Document Type: Article

References (40)

1. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B (1985) Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28:302-307
2. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657-686
3. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM (2008) Prevalence and spread of extended-spectrum beta-lactamaseproducing Enterobacteriaceae in Europe. Clin Microbiol Infect 14(Suppl 1):144-153
4. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tortola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Pena C, Llanos AC, Canton R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamaseproducing Escherichia coli. Arch Intern Med 168:1897-1902
5. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Ruiz M, Pena C, Almela M, Almirante B, Grill F, Colomina J, Gimenez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A (2010) Community-onset bacteremia due to extended-spectrum betalactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50:40-48
6. Lavigne JP, Marchandin H, Delmas J, Moreau J, Bouziges N, Lecaillon E, Cavalie L, Jean-Pierre H, Bonnet R, Sotto A (2007) CTX-M beta-lactamaseproducing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J Clin Microbiol 45:620-626
7. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E (2005) Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 40:1317-1324
8. Hsieh CJ, Shen YH, Hwang KP (2010) Clinical implications, risk factors and mortality following community-onset bacteremia caused by extendedspectrum beta-lactamase (ESBL) and non-ESBL producing Escherichia coli. J Microbiol Immunol Infect 43:240-248
9. Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum betalactamases. J Antimicrob Chemother 57:780-783
10. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y (2009) A multinational survey of risk factors for infection with extendedspectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682-690
11. Drieux L, Brossier F, Duquesnoy O, Aubry A, Robert J, Sougakoff W, Lecso-Bornet M, Jarlier V (2009) Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamaseproducing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis 28:491-498
12. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D (2000) Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 45:895-898
13. European Centre for Disease Surveillance and Control-EARS-Net Antimicrobial Resistance Surveillance in Europe (2010). http://ecdc.europa.eu/ en/publications/Publications/1111-SUR-AMR-data.pdf.pdf
14. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP (2006) Impact of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27:1226-1232
15. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162-1171
16. Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K (2005) Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibioticresistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 26:575-579
17. de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch A, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Melbarde Kelmere A, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L, Grundmann H (2011) Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third generation cephalosporins. J Antimicrob Chemother 66:398-407
18. Karah N, Haldorsen B, Hermansen NO, Tveten Y, Ragnhildstveit E, Skutlaberg DH, Tofteland S, Sundsfjord A, Samuelsen O (2011) Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J Med Microbiol 60:515-521
19. Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D, Wang H (2011) High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenemresistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother 55:2493-2494
20. Munoz-Price LS, De La Cuesta C, Adams S, Wyckoff M, Cleary T, McCurdy SP, Huband MD, Lemmon MM, Lescoe M, Dibhajj FB, Hayden MK, Lolans K, Quinn JP (2010) Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemaseproducing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 31:1074-1077
21. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12
22. Bonten MJ, Weinstein RA (1996) The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol 17:193-200
23. Clinical Laboratory Standards Institute, Wayne (PA) (2006) Performance standards for antimicrobial susceptibility testing. 16th informational supplement (M100-S16)
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
25. Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, Furuno JP (2009) Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol 32:481-489
26. Peduzzi P, Concato J, Feinstein AR, Holford TR (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503-1510
27. Thouverez M, Talon D, Bertrand X (2004) Control of Enterobacteriaceae producing extended-spectrum betalactamase in intensive care units: rectal screening may not be needed in nonepidemic situations. Infect Control Hosp Epidemiol 25:838-841
28. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG Jr (2007) Risk factors for colonization with extendedspectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 13:1144-1149
29. Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, Yinnon AM (2009) Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 30:534-542
30. Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, Poddar B, Mishra A, Gurjar M, Dhole TN (2010) Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum betalactamase- and metallo-beta-lactamaseproducing Gram-negative bacteria - an Indian experience. J Med Microbiol 59:955-960
31. Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, Humar A (2002) Is surveillance for multidrugresistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 186:1754-1760
32. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N (2010) Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31:1250-1256
33. Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, Garrigosa F, Ariza J, Gudiol F (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum betalactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35:9-16
34. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 42:925-934
35. Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, Strauss SM, Johnson JA (2007) Patient-topatient transmission is important in extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae acquisition. Clin Infect Dis 45:1347-1350
36. Guet-Revillet H, Le Monnier A, Breton N, Descamps P, Lecuyer H, Alaabouche I, Bureau C, Nassif X, Zahar JR (2012) Environmental contamination with extended-spectrum beta-lactamases: is there any difference between Escherichia coli and Klebsiella spp? Am J Infect Control
37. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL (2004) Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum betalactamases. Clin Infect Dis 39:31-37
38. Lipworth AD, Hyle EP, Fishman NO, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Kasbekar N, Lautenbach E (2006) Limiting the emergence of extended-spectrum beta-lactamaseproducing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 27:279-286
39. Rice LB, Eckstein EC, DeVente J, Shlaes DM (1996) Ceftazidimeresistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23:118-124
40. American Thoracic Society and Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med 171:388-416